Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,645 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

NCT01275625

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Regional Center on AIDS and Infectious Diseases Prophylaxis and Control Krasnoyarsk, Russia
  • Federal scientific and methodological center on AIDS prophylaxis and control Moscow, Russia
  • Moscow regional center on AIDS and infectious diseases prophylaxis and control Moscow, Russia
  • Regional Center on AIDS and Infectious Diseases Prophylaxis and Control Nizhny Novgorod, Russia
View Trial Details
Completed

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

NCT00130286

Conditions
Blood-Borne Infections, Body Weight, Body Weight Changes, +28 more
Locations
  • AIDS Community Research Initiative of America (ACRIA) New York, United States
  • Cornell HIV Clinical Trials Unit, Weill Medical College of Cornell University New York, United States
  • St. Luke's-Roosevelt Hospital Center New York, United States
  • Columbia University College of Physicians and Surgeons New York, United States
View Trial Details
Completed

Early Versus Delayed Pneumococcal Vaccination in HIV

NCT00137605

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +16 more
Locations
  • Medical Arts Health Research Group Kelowna, British Columbia, Canada
  • Downtown IDC Vancouver, British Columbia, Canada
  • St. Paul's Hospital Vancouver, British Columbia, Canada
  • St. Boniface General Hospital Winnipeg, Manitoba, Canada
View all 14 locations
View Trial Details
Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

NCT01593046

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Daytona Beach, Florida, United States
  • GSK Investigational Site Overland Park, Kansas, United States
View Trial Details

Related conditions